Nanobiotix appoints Thierry Otin as Head of Manufacturing and Supply

French nanomedicine company Nanobiotix (Euronext: NANO–ISIN) has announced the appointment of Thierry Otin (pictured) as Head of Manufacturing and Supply.

The appointment strengthens the Nanobiotix organisation, as Mr Otin will be responsible for the manufacturing plans to move the lead product, NBTXR3, from clinical trials into full commercialization as from 2016.

Prior to joining Nanobiotix, Mr Otin was the Quality Site Manager (EU Sterile) at Roche and before then he worked at LFB Biotechnologies as the Head Pharmacist (Pharmaceutical Qualified Person) and Quality Director. Prior to this, he worked in QA/GMP and manufacturing with world class companies including, Schering CISBiointernational, Institut de Formation des Industries de Santé (IFIS), UCB, Delagrange and Rhône-Poulenc (Roger Bellon and Specia). He has a degree in biology and has a doctorate in Pharmacy from the University of Strasbourg.